Login to Your Account



Pharma: Other News To Note


Wednesday, July 24, 2013

• Novartis AG, of Basel, Switzerland, and Baylor Research Institute, the research arm of Baylor Health Care System, signed a deal for Novartis to exclusively license Baylor's patents pertaining to the treatment of systemic onset juvenile idiopathic arthritis using interleukin-1 beta agonists.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription